Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Biomarkers × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 7 Neoplasms 3 Lung Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion 1 Pituitary Diseases 1 Pituitary ACTH Hypersecretion 1 Obesity 1 Myasthenia Gravis 1 Motor Activity 1 Lymphoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Cardiotoxicity 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Docetaxel 260 Prednisone 203 enzalutamide 164 Leuprolide 159 Radiotherapy 152 Abiraterone Acetate 143 Magnetic Resonance Spectroscopy 138 bicalutamide 115 Goserelin 114 Androgen Antagonists 102 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 96 Radiosurgery 96 apalutamide 79 gallium 68 PSMA-11 67 Specimen Handling 66 abiraterone 65 darolutamide 55 Gonadotropin-Releasing Hormone 53 Biopsy 53 Surveys and Questionnaires 51 Radiation 51 Brachytherapy 49 cabazitaxel 47 Triptorelin Pamoate 46 Standard of Care 44 pembrolizumab 43 Zoledronic Acid 43 luprolide acetate gel depot 42 Radiotherapy, Intensity-Modulated 41 Estramustine 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01838265 2014-12-08

MGM

University of Miami

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡